Prescription Drug Monitoring Act of 2021
- Last Action
- 4/2/2021
Actions
- 2021-04-02Referred to the Subcommittee on Health.
- 2021-04-01Referred to the House Committee on Energy and Commerce.
- 2021-04-01Introduced in House
- 2021-04-01Introduced in House
CRS Summary
As of 2021-04-01 (00)
Prescription Drug Monitoring Act of 2021
This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs.
States or territories that receive this funding must require
- prescribers to consult the PDMP before starting treatment with such drugs, and
- dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs.
In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.
Cosponsors (1)
- Troy Balderson (R-OH)
Subjects
- Criminal justice information and records
- Drug trafficking and controlled substances
- Health information and medical records
- Health personnel
- Intergovernmental relations
- Licensing and registrations
- Medical ethics
- Prescription drugs
- State and local government operations
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.